TY - JOUR
T1 - Summary of presentations from the 46th annual meeting of the american society of clinical oncology (2010)
T2 - Focus on developmental therapeutics related to lung cancer
AU - Morgensztern, Daniel
AU - Pennell, Nathan A.
AU - Subramanian, Janakiraman
AU - Govindan, Ramaswamy
PY - 2011/3
Y1 - 2011/3
N2 - A number of novel agents are currently being tested in clinical trials in patients with cancer. Results from early-phase trials, often in unselected groups of patients with a wide variety of cancer types, were reported at the 46th annual meeting of the American Society of Clinical Oncology (ASCO). We report on selected studies from the developmental therapeutics track (abstracts 2500-2613 and 3000-3108) that may be of interest to the thoracic oncology community.
AB - A number of novel agents are currently being tested in clinical trials in patients with cancer. Results from early-phase trials, often in unselected groups of patients with a wide variety of cancer types, were reported at the 46th annual meeting of the American Society of Clinical Oncology (ASCO). We report on selected studies from the developmental therapeutics track (abstracts 2500-2613 and 3000-3108) that may be of interest to the thoracic oncology community.
KW - ASCO
KW - Developmental therapeutics
KW - Targeted therapy
UR - http://www.scopus.com/inward/record.url?scp=79959339450&partnerID=8YFLogxK
U2 - 10.1016/j.cllc.2011.03.003
DO - 10.1016/j.cllc.2011.03.003
M3 - Review article
C2 - 21550555
AN - SCOPUS:79959339450
SN - 1525-7304
VL - 12
SP - 94
EP - 99
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
IS - 2
ER -